LEADER-PAD
The Low dose ColchicinE in pAtients with peripheral Artery DiseasE to address residual vascular Risk (LEADER-PAD) trial will evaluate if anti-inflammatory therapy with colchicine will reduce vascular events in patients with symptomatic peripheral…
- Investigator
- Samir K Shah
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
STRIDE II
- Investigator
- Benjamin N Jacobs
- Status
- Accepting Candidates
REGAIN
A novel temporary peripheral nerve stimulation system that delivers a single dose of electrical stimulation therapy for 1 hour will be evaluated for safety and effectiveness.
- Investigator
- Ellen Satteson
- Status
- Accepting Candidates
- Ages
- 18 Years - 65 Years
- Sexes
- All